| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 44.04 mm | 44.04 mm | 44.04 mm | 44.04 mm | 44.04 mm | 44.04 mm |
| Cash burn (monthly) | 19.45 mm | 2.85 mm | 13.39 mm | 10.68 mm | 2.66 mm | 6.28 mm |
| Cash used (since last report) | 511.55 mm | 74.86 mm | 352.20 mm | 280.93 mm | 69.92 mm | 165.29 mm |
| Cash remaining | -467.51 mm | -30.82 mm | -308.16 mm | -236.89 mm | -25.89 mm | -121.25 mm |
| Runway (months of cash) | -24.0 | -10.8 | -23.0 | -22.2 | -9.7 | -19.3 |
| 13F holders | Current |
|---|---|
| Total holders | 2 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 42.35 mm |
| Total shares | 3.62 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| AMGN Amgen | 2.50 mm | $42.35 mm |
| Venrock Healthcare Capital Partners II | 1.12 mm | $0.00 |
